Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy
We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observ...
Gespeichert in:
| Veröffentlicht in: | Lupus 2006-01, Vol.15 (12), p.881-885 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 885 |
|---|---|
| container_issue | 12 |
| container_start_page | 881 |
| container_title | Lupus |
| container_volume | 15 |
| creator | Micheloud, D Nuño, L Rodríguez-Mahou, M Sánchez-Ramón, S Ortega, M C Aguarón, A Junco, E Carbone, J Fernández-Cruz, E Carreño, L López-Longo, F J |
| description | We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observed either in clinical symptoms or in laboratory examinations during pregnancy or after delivery. Her autoantibodies except fluorescent anti-nuclear antibodies were negative. We suggest that a combination of anti-TNF-alpha, plasmapheresis and high-dose intravenous gammaglobulin may be a safe and effective therapy for pregnant patients suffering severe lupus nephritis. |
| doi_str_mv | 10.1177/0961203306070970 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68283935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0961203306070970</sage_id><sourcerecordid>19498997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-88cc035b03127c69ad629755dd3680990abde3fd91a016919c45c459921e62863</originalsourceid><addsrcrecordid>eNqFkctq3DAUhkVpaSbT7rsqoous6lSXseSzLGHSFALZtGsj6-JRsGVXkgN-pr5kNZ2BQKAUBIJzvv8_N4Q-UHJNqZRfCAjKCOdEEElAkldoQ3dSViXOXqPNMV0d8xfoMqVHQginIN6iCyoZpQD1Bv3eO-e10itWweCknM0rnhzeZxVs1HbOn_HB94fKTMliH3JUTzZMS8K9GkfVD1O3DD78Vc-DSqOaDzba5BPW09j5YA3OJaLmFbsp4mGZi9Z455biN8dp8K5ks3-yONj5EH0-SeehtJV96Atk-6CCXt-hN04Nyb4__1v083b_4-auun_49v3m632lOfBcNY3WhNddGZZJLUAZwUDWtTFcNASAqM5Y7gxQRagACnpXlwfAqBWsEXyLrk6-pb1fi025HX3SdhjKSsrkrWhYUyrV_wUp7KABkAX89AJ8nJYYyhAtY0xwyovfFpETpOOUUrSunaMfVVxbStrjuduX5y6Sj2ffpRuteRac71uA6gQk1dvnov80_AP7VLUx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222631339</pqid></control><display><type>article</type><title>Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy</title><source>MEDLINE</source><source>Sage Journals</source><creator>Micheloud, D ; Nuño, L ; Rodríguez-Mahou, M ; Sánchez-Ramón, S ; Ortega, M C ; Aguarón, A ; Junco, E ; Carbone, J ; Fernández-Cruz, E ; Carreño, L ; López-Longo, F J</creator><creatorcontrib>Micheloud, D ; Nuño, L ; Rodríguez-Mahou, M ; Sánchez-Ramón, S ; Ortega, M C ; Aguarón, A ; Junco, E ; Carbone, J ; Fernández-Cruz, E ; Carreño, L ; López-Longo, F J</creatorcontrib><description>We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observed either in clinical symptoms or in laboratory examinations during pregnancy or after delivery. Her autoantibodies except fluorescent anti-nuclear antibodies were negative. We suggest that a combination of anti-TNF-alpha, plasmapheresis and high-dose intravenous gammaglobulin may be a safe and effective therapy for pregnant patients suffering severe lupus nephritis.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1177/0961203306070970</identifier><identifier>PMID: 17211995</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adult ; Combined Modality Therapy ; Etanercept ; Female ; Humans ; Immunoglobulin G - administration & dosage ; Immunoglobulin G - adverse effects ; Immunoglobulins, Intravenous ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - adverse effects ; Infant, Newborn ; Lupus Nephritis - drug therapy ; Male ; Plasmapheresis ; Pregnancy ; Pregnancy Complications - drug therapy ; Pregnancy Outcome ; Receptors, Tumor Necrosis Factor - administration & dosage</subject><ispartof>Lupus, 2006-01, Vol.15 (12), p.881-885</ispartof><rights>2006 Sage</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-88cc035b03127c69ad629755dd3680990abde3fd91a016919c45c459921e62863</citedby><cites>FETCH-LOGICAL-c393t-88cc035b03127c69ad629755dd3680990abde3fd91a016919c45c459921e62863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0961203306070970$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0961203306070970$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17211995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Micheloud, D</creatorcontrib><creatorcontrib>Nuño, L</creatorcontrib><creatorcontrib>Rodríguez-Mahou, M</creatorcontrib><creatorcontrib>Sánchez-Ramón, S</creatorcontrib><creatorcontrib>Ortega, M C</creatorcontrib><creatorcontrib>Aguarón, A</creatorcontrib><creatorcontrib>Junco, E</creatorcontrib><creatorcontrib>Carbone, J</creatorcontrib><creatorcontrib>Fernández-Cruz, E</creatorcontrib><creatorcontrib>Carreño, L</creatorcontrib><creatorcontrib>López-Longo, F J</creatorcontrib><title>Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy</title><title>Lupus</title><addtitle>Lupus</addtitle><description>We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observed either in clinical symptoms or in laboratory examinations during pregnancy or after delivery. Her autoantibodies except fluorescent anti-nuclear antibodies were negative. We suggest that a combination of anti-TNF-alpha, plasmapheresis and high-dose intravenous gammaglobulin may be a safe and effective therapy for pregnant patients suffering severe lupus nephritis.</description><subject>Adult</subject><subject>Combined Modality Therapy</subject><subject>Etanercept</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin G - administration & dosage</subject><subject>Immunoglobulin G - adverse effects</subject><subject>Immunoglobulins, Intravenous</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Infant, Newborn</subject><subject>Lupus Nephritis - drug therapy</subject><subject>Male</subject><subject>Plasmapheresis</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Pregnancy Outcome</subject><subject>Receptors, Tumor Necrosis Factor - administration & dosage</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkctq3DAUhkVpaSbT7rsqoous6lSXseSzLGHSFALZtGsj6-JRsGVXkgN-pr5kNZ2BQKAUBIJzvv8_N4Q-UHJNqZRfCAjKCOdEEElAkldoQ3dSViXOXqPNMV0d8xfoMqVHQginIN6iCyoZpQD1Bv3eO-e10itWweCknM0rnhzeZxVs1HbOn_HB94fKTMliH3JUTzZMS8K9GkfVD1O3DD78Vc-DSqOaDzba5BPW09j5YA3OJaLmFbsp4mGZi9Z455biN8dp8K5ks3-yONj5EH0-SeehtJV96Atk-6CCXt-hN04Nyb4__1v083b_4-auun_49v3m632lOfBcNY3WhNddGZZJLUAZwUDWtTFcNASAqM5Y7gxQRagACnpXlwfAqBWsEXyLrk6-pb1fi025HX3SdhjKSsrkrWhYUyrV_wUp7KABkAX89AJ8nJYYyhAtY0xwyovfFpETpOOUUrSunaMfVVxbStrjuduX5y6Sj2ffpRuteRac71uA6gQk1dvnov80_AP7VLUx</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Micheloud, D</creator><creator>Nuño, L</creator><creator>Rodríguez-Mahou, M</creator><creator>Sánchez-Ramón, S</creator><creator>Ortega, M C</creator><creator>Aguarón, A</creator><creator>Junco, E</creator><creator>Carbone, J</creator><creator>Fernández-Cruz, E</creator><creator>Carreño, L</creator><creator>López-Longo, F J</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20060101</creationdate><title>Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy</title><author>Micheloud, D ; Nuño, L ; Rodríguez-Mahou, M ; Sánchez-Ramón, S ; Ortega, M C ; Aguarón, A ; Junco, E ; Carbone, J ; Fernández-Cruz, E ; Carreño, L ; López-Longo, F J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-88cc035b03127c69ad629755dd3680990abde3fd91a016919c45c459921e62863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Combined Modality Therapy</topic><topic>Etanercept</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin G - administration & dosage</topic><topic>Immunoglobulin G - adverse effects</topic><topic>Immunoglobulins, Intravenous</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Infant, Newborn</topic><topic>Lupus Nephritis - drug therapy</topic><topic>Male</topic><topic>Plasmapheresis</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Pregnancy Outcome</topic><topic>Receptors, Tumor Necrosis Factor - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Micheloud, D</creatorcontrib><creatorcontrib>Nuño, L</creatorcontrib><creatorcontrib>Rodríguez-Mahou, M</creatorcontrib><creatorcontrib>Sánchez-Ramón, S</creatorcontrib><creatorcontrib>Ortega, M C</creatorcontrib><creatorcontrib>Aguarón, A</creatorcontrib><creatorcontrib>Junco, E</creatorcontrib><creatorcontrib>Carbone, J</creatorcontrib><creatorcontrib>Fernández-Cruz, E</creatorcontrib><creatorcontrib>Carreño, L</creatorcontrib><creatorcontrib>López-Longo, F J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Micheloud, D</au><au>Nuño, L</au><au>Rodríguez-Mahou, M</au><au>Sánchez-Ramón, S</au><au>Ortega, M C</au><au>Aguarón, A</au><au>Junco, E</au><au>Carbone, J</au><au>Fernández-Cruz, E</au><au>Carreño, L</au><au>López-Longo, F J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>15</volume><issue>12</issue><spage>881</spage><epage>885</epage><pages>881-885</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observed either in clinical symptoms or in laboratory examinations during pregnancy or after delivery. Her autoantibodies except fluorescent anti-nuclear antibodies were negative. We suggest that a combination of anti-TNF-alpha, plasmapheresis and high-dose intravenous gammaglobulin may be a safe and effective therapy for pregnant patients suffering severe lupus nephritis.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>17211995</pmid><doi>10.1177/0961203306070970</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0961-2033 |
| ispartof | Lupus, 2006-01, Vol.15 (12), p.881-885 |
| issn | 0961-2033 1477-0962 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68283935 |
| source | MEDLINE; Sage Journals |
| subjects | Adult Combined Modality Therapy Etanercept Female Humans Immunoglobulin G - administration & dosage Immunoglobulin G - adverse effects Immunoglobulins, Intravenous Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Infant, Newborn Lupus Nephritis - drug therapy Male Plasmapheresis Pregnancy Pregnancy Complications - drug therapy Pregnancy Outcome Receptors, Tumor Necrosis Factor - administration & dosage |
| title | Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A35%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20Etanercept,%20high-dose%20intravenous%20gammaglobulin%20and%20plasmapheresis%20combined%20therapy%20for%20lupus%20diffuse%20proliferative%20nephritis%20complicating%20pregnancy&rft.jtitle=Lupus&rft.au=Micheloud,%20D&rft.date=2006-01-01&rft.volume=15&rft.issue=12&rft.spage=881&rft.epage=885&rft.pages=881-885&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1177/0961203306070970&rft_dat=%3Cproquest_cross%3E19498997%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222631339&rft_id=info:pmid/17211995&rft_sage_id=10.1177_0961203306070970&rfr_iscdi=true |